Transforming nucleic acid delivery
Introducing a proprietary nucleic acid delivery platform replacing lipid nanoparticles enabling:
Safe and effective RNA/DNA delivery
Cost-effective and scalable manufacturing
Durable expression with ability to deliver large/complex cargos
No screening required (single platform design for all targets)
Simple administration by minimally trained personnel
Ultralow-cost and disposable for single-use (or repeated use if desired)
Meet Piezo’s platform.
Developed by Georgia Tech researchers, it combines two powerful drug delivery technologies (electric pulses and microneedles) into a simple, small, and low-cost form factor never before achieved.
Our Vision.
RNA and DNA medicines will drive the next generation of preventative and personalized medicine, but need to have improvements in delivery.
We aim to improve the safety, affordability, and global accessibility of mRNA vaccines, and extend to a broader mission of enabling therapies using improved RNA and DNA delivery.
Our approach has the potential to enable a wide range of nucleic acid medicines for vaccines, immunotherapies, therapeutic proteins, and even gene therapies.
Work with us to deliver your therapeutic.